Literature DB >> 2468427

Occurrence of an anti-peplomycin IgE antibody cross-reacting with bleomycin in a patient with cervical uterine cancer.

H Sakura1, T Fujii, T Ohashi, S Tsuruta.   

Abstract

An allergic reaction to peplomycin was observed in a patient with cervical uterine cancer who had previously been treated with peplomycin. A positive Prausnitz-Küstner test and its elimination after heat treatment of the serum showed the production of anti-peplomycin IgE antibody. Peplomycin was coupled to a paper disc and a sensitive radioallergosorbent test for peplomycin was developed to quantitate the antibody. Patient serum IgE and IgG were purified by DE52 column chromatography; the IgE fraction contained binding activity to peplomycin. A competition test revealed that the antibody bound to both peplomycin and bleomycin. DNA, RNA, and mononucleotides had no effect on antibody binding, but the antibody inhibited peplomycin's activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468427     DOI: 10.1007/bf00292416

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  8 in total

1.  Diagnosis of allergy by an in-vitro test for allergen antibodies.

Authors:  L Wide; H Bennich; S G Johansson
Journal:  Lancet       Date:  1967-11-25       Impact factor: 79.321

2.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

3.  Thermally induced structural changes in immunoglobulin E.

Authors:  K J Dorrington; H Bennich
Journal:  J Biol Chem       Date:  1973-12-25       Impact factor: 5.157

4.  Enzyme immunoassay for pepleomycin, a new bleomycin analog.

Authors:  K Fujiwara; M Yasuno; T Kitagawa
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

5.  Fundamental and clinical studies on new bleomycin analogs.

Authors:  A Matsuda; O Yoshioka; T Yamashita; K Ebihara; H Umezawa; T Miura; K Katayama; M Yokoyama; S Nagai
Journal:  Recent Results Cancer Res       Date:  1978

6.  New antibiotics, bleomycin A and B.

Authors:  H Umezawa; K Maeda; T Takeuchi; Y Okami
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

7.  Development and application of a radioimmunoassay for pepleomycin.

Authors:  G W Aherne; N Saesow; S James; V Marks
Journal:  Cancer Treat Rep       Date:  1982-06

8.  Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.

Authors:  B I Sikic; Z H Siddik; T E Gram
Journal:  Cancer Treat Rep       Date:  1980 Apr-May
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.